These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20457915)

  • 1. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
    Simon A; Park H; Maddipati R; Lobito AA; Bulua AC; Jackson AJ; Chae JJ; Ettinger R; de Koning HD; Cruz AC; Kastner DL; Komarow H; Siegel RM
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9801-6. PubMed ID: 20457915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAPS mutations in
    Akagi T; Hiramatsu-Asano S; Ikeda K; Hirano H; Tsuji S; Yahagi A; Iseki M; Matsuyama M; Mak TW; Nakano K; Ishihara K; Morita Y; Mukai T
    Front Immunol; 2022; 13():926175. PubMed ID: 35936010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
    Negm OH; Mannsperger HA; McDermott EM; Drewe E; Powell RJ; Todd I; Fairclough LC; Tighe PJ
    Eur J Immunol; 2014 Jul; 44(7):2096-110. PubMed ID: 24668260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
    Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
    Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).
    Lobito AA; Kimberley FC; Muppidi JR; Komarow H; Jackson AJ; Hull KM; Kastner DL; Screaton GR; Siegel RM
    Blood; 2006 Aug; 108(4):1320-7. PubMed ID: 16684962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
    Todd I; Negm OH; Reps J; Radford P; Figueredo G; McDermott EM; Drewe E; Powell RJ; Bainbridge S; Hamed M; Crouch S; Garibaldi J; St-Gallay S; Fairclough LC; Tighe PJ
    Pharmacol Res; 2017 Nov; 125(Pt B):188-200. PubMed ID: 28860008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.
    Fairclough LC; Stoop AA; Negm OH; Radford PM; Tighe PJ; Todd I
    Eur J Immunol; 2015 Oct; 45(10):2937-44. PubMed ID: 26202849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome.
    Dickie LJ; Aziz AM; Savic S; Lucherini OM; Cantarini L; Geiler J; Wong CH; Coughlan R; Lane T; Lachmann HJ; Hawkins PN; Robinson PA; Emery P; McGonagle D; McDermott MF
    Ann Rheum Dis; 2012 Dec; 71(12):2035-43. PubMed ID: 22679299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion.
    Turner MD; Chaudhry A; Nedjai B
    Biosci Rep; 2012 Apr; 32(2):105-12. PubMed ID: 22115362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).
    Bulua AC; Simon A; Maddipati R; Pelletier M; Park H; Kim KY; Sack MN; Kastner DL; Siegel RM
    J Exp Med; 2011 Mar; 208(3):519-33. PubMed ID: 21282379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
    Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
    Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.
    Jéru I; Charmion S; Cochet E; Copin B; Duquesnoy P; Garcia MT; Le Borgne G; Cathebras P; Gaillat J; Karabina S; Dodé C; Lohse P; Hentgen V; Amselem S
    PLoS One; 2013; 8(7):e69757. PubMed ID: 23894535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
    Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
    J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases.
    Bachetti T; Ceccherini I
    J Mol Med (Berl); 2014 Jun; 92(6):583-94. PubMed ID: 24706103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three
    Harrison SR; Scambler T; Oubussad L; Wong C; Wittmann M; McDermott MF; Savic S
    Front Immunol; 2018; 9():173. PubMed ID: 29467762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
    Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.